Clear Cell Sarcoma
📧 Sign up to get email alerts when something new happens for Clear Cell Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating alpha/beta T and B cell depletion with zoledronic acid for solid tumors; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group [NA]
An ongoing clinical trial under the MIRAS project aims to perform multimodal immune characterization of rare soft tissue sarcomas and relate…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma [Phase 2]
A Phase II study of tebentafusp in HLA-A*02:01 positive patients with advanced clear cell sarcoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Vebreltinib for Advanced or Metastatic CCS [Phase 2]
A Phase 2 clinical trial evaluating Vebreltinib in advanced or metastatic clear cell sarcoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell Sarcoma [Phase 2]
Phase 2 trial QUILT-3.031 evaluating AMG 337 in advanced or metastatic clear cell sarcoma was terminated; results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: CREATE: Cross-tumoral Phase 2 With Crizotinib [Phase 2]
Phase 2 cross-tumor trial evaluating crizotinib in multiple locally advanced or metastatic cancers; study completed.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) [Phase 1, Phase 2]
A rollover protocol update is described to allow continued access to the LSD1 inhibitor seclidemstat (SP-2577) in ongoing Phase 1/Phase 2 tr…
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Phase 2 Study in Patients With MiT Tumors [Phase 2]
Phase 2 study of tivantinib in MiT family tumors including renal cell carcinoma, alveolar soft part sarcoma, and clear cell sarcoma has been…